Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00162344 · ClinicalTrials.gov registry record · Phase 4
A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.
A Phase 4 study, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 205
- Enrollment target
NCT00162344: Completed Phase 4 study, sponsored by Lantheus Medical Imaging.
NCT00162344 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 205 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00162344, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 205 participants
- Enrollment target
Study Summary
The study is designed to see if stress heart imaging can be used as a screening exam in patients with diabetes and risk factors of developing of coronary artery disease and experiencing future cardiac events.
Interventions
- DRUG Technetium Tc99m Sestamibi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
What the finished NCT00162344 record still lists
NCT00162344 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 1 intervention - of which Technetium Tc99m Sestamibi is the first listed.
NCT00162344 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00162344 about?
NCT00162344 is a clinical study titled "A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.". The study is designed to see if stress heart imaging can be used as a screening exam in patients with diabetes and risk factors of developing of coronary artery disease and experiencing future cardiac events.
What is the current status of trial NCT00162344?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 205 participants. The study started on 2003-12. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00162344?
The interventions under investigation include: Technetium Tc99m Sestamibi (DRUG).
Who is sponsoring clinical trial NCT00162344?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00162344's enrollment target sits among peer trials
205 402nd of 2000 higher than 1,599 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia